BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32298455)

  • 1. Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative.
    Milliken P; Aylott M; Edmunds N; Engle S; Ewart L; Fleurance R; Guffroy M; Hargreaves A; Heinz-Taheny K; Kirk S; Leishman D; Leong L; McMahon N; Valentin JP; Watson D; Wallis R; Clements P
    Toxicol Sci; 2020 Jul; 176(1):224-235. PubMed ID: 32298455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP).
    Kremer JJ; Bills AJ; Hanke NJ; Chen H; Meier WA; Osinski MA; Foley CM
    J Pharmacol Toxicol Methods; 2015; 75():27-37. PubMed ID: 26001324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogs.
    Regan CP; Stump GL; Detwiler TJ; Chen L; Regan HK; Gilberto DB; DeGeorge JJ; Sannajust FJ
    J Pharmacol Toxicol Methods; 2016; 81():107-14. PubMed ID: 27166580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of housing conditions on baseline cardiovascular parameters and the sensitivity to detect changes in contractility in telemetry-implanted dogs.
    Sadekova N; Boudreau G; Jalbert B; Norton K
    J Pharmacol Toxicol Methods; 2016; 81():60-74. PubMed ID: 27163176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
    Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
    J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs.
    Cordes JS; Heyen JR; Volberg ML; Poy N; Kreuser S; Shoieb AM; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2016; 79():72-9. PubMed ID: 26844408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
    Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2021; 109():107066. PubMed ID: 33838254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of freely-moving telemetry Chinese Miniature Experiment Pigs (CMEPs) to beagle dogs in cardiovascular safety pharmacology studies.
    Yuan H; Zhao J; Guo J; Wu R; He L; Cui Y; Feng M; Zhang T; Hou M; Guo Q; Zhang L; Jia L; Huang C; Ye L; Peng S
    J Pharmacol Toxicol Methods; 2014; 70(1):19-28. PubMed ID: 24721420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical cardiovascular safety assessment of pharmacology-toxicology relationship for a set of novel kinase inhibitors.
    Koshman YE; Kohnken R; Logan MR; Mittelstadt SW; Foley CM
    Toxicol Sci; 2024 Mar; 198(2):316-327. PubMed ID: 38191231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
    Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2021; 111():107109. PubMed ID: 34416395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog.
    Taylor GL; Patel B; Sullivan AT
    J Pharmacol Toxicol Methods; 2007; 56(2):212-7. PubMed ID: 17582788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.
    Sivarajah A; Collins S; Sutton MR; Regan N; West H; Holbrook M; Edmunds N
    J Pharmacol Toxicol Methods; 2010; 62(1):12-9. PubMed ID: 20570743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
    Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
    J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of non-invasive and implanted telemetric measurement of blood pressure and electrocardiogram in conscious beagle dogs.
    Ward G; Milliken P; Patel B; McMahon N
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):106-13. PubMed ID: 22525003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concordance between nonclinical and phase I clinical cardiovascular assessment from a cross-company data sharing initiative.
    Ewart L; Aylott M; Deurinck M; Engwall M; Gallacher DJ; Geys H; Jarvis P; Ju H; Leishman D; Leong L; McMahon N; Mead A; Milliken P; Suter W; Teisman A; Van Ammel K; Vargas HM; Wallis R; Valentin JP
    Toxicol Sci; 2014 Dec; 142(2):427-35. PubMed ID: 25246669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the PhysioTel™ Digital M11 cardiovascular telemetry implant in socially housed cynomolgus monkeys up to 16weeks after surgery.
    Andersen NK; Meyer O; Bradley A; Dragsted N; Lassen AB; Sjögren I; Larsen JM; Harvey W; Bator R; Milne A
    J Pharmacol Toxicol Methods; 2017 Sep; 87():82-92. PubMed ID: 28416413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
    Takahara A; Dohmoto H; Yoshimoto R; Sugiyama A; Hashimoto K
    Eur J Pharmacol; 2001 Feb; 413(1):101-8. PubMed ID: 11173068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.